Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>Resources>Application Notes>This Application Note
  Application Notes
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Cancer Related Immune Response Genes Uncovered
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer.
Deciphering Inactive X Chromosomes
Untangling the Barr body of inactive X chromosomes valuable for understanding chromosome structure and gene expression.
Micro Disease-Detecting Sensor Created
Researchers at McMaster University have created a microscopic disease-detecting sensor that can turn on to detect trace amounts of substances.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Uncovering a New Principle in Chemotherapy Resistance in Breast Cancer
The NIH study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
Scroll Up
Scroll Down

Efficient PCR from whole blood using Finnzymes High Performance PCR solution
Bookmark and Share

Labtech International

Finnzymes have developed a range of reagents,consumables and instrumentation to allow fastPCR in inhibiting conditions. Here we describean application for amplifying exogenous andhuman genomic DNA from whole blood withoutthe need for DNA purification, and use ofspecial buffers or complicated protocols.Finnzymes' solution for High Performance (HP)-PCR results in faster amplification with betteryields for raw blood samples as compared withconventional methods for PCR.

Finnzymes’ HP-PCR is a tripartite solution focused onspeeding up a PCR and providing marked improvementsin yield while maintaining high fidelity. The uniquecombination of our highly processive PhusionTM DNAPolymerases, quick PikoTM Thermal Cyclers and ultra-thinwalled UTWTM tubes provides considerable benefits to thespeed, yield, fidelity, specificity and robustness of PCR.Central to these improvements is our Phusion technology,which enhances activity by way of a double-strandedDNA-binding domain bound to a highly engineeredproofreading polymerase. This dsDNA-binding domainallows for ultra-robust reactions by tethering thepolymerase to the duplex DNA, driving much higherassociation constants, so the effects of conventionalinhibitors of PCR are significantly reduced1. Here wedescribe one such application, a simple protocol for robustamplification of DNA from whole blood. Whole blood isoften used in clinical diagnostics and as a DNA source forPCR tests. Unfortunately, Taq DNA polymerase, the mostcommonly used enzyme for PCR, is known to becompletely inhibited by even small quantities of wholeblood in the reaction2. Several strategies have been usedto overcome this difficulty, including the use of specializedpurifications, buffers and pretreatments3,4, but all of thesemethods have drawbacks, adding time and cost, and oftenproducing inconsistent results. As a consequence,purification of genomic DNA from whole blood remains acommon practice even though it adds considerable timeand expense to the test.

Further Information


Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!